The WACC of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 5.0%.
Range | Selected | |
Cost of equity | 5.2% - 7.4% | 6.3% |
Tax rate | 27.7% - 30.6% | 29.15% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 4.0% - 6.1% | 5.0% |
Category | Low | High |
Long-term bond rate | 1.4% | 1.9% |
Equity market risk premium | 6.1% | 7.1% |
Adjusted beta | 0.62 | 0.71 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.2% | 7.4% |
Tax rate | 27.7% | 30.6% |
Debt/Equity ratio | 1.12 | 1.12 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 4.0% | 6.1% |
Selected WACC | 5.0% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
4506.T | Sumitomo Dainippon Pharma Co Ltd | 1.12 | 1.45 | 0.82 |
4516.T | Nippon Shinyaku Co Ltd | 0.01 | 0.64 | 0.64 |
4521.T | Kaken Pharmaceutical Co Ltd | 0.02 | 0.28 | 0.28 |
4528.T | Ono Pharmaceutical Co Ltd | 0.01 | 0.34 | 0.34 |
4530.T | Hisamitsu Pharmaceutical Co Inc | 0.01 | 0.2 | 0.2 |
4536.T | Santen Pharmaceutical Co Ltd | 0.07 | 0.49 | 0.47 |
4539.T | Nippon Chemiphar Co Ltd | 2.61 | 0.2 | 0.07 |
4541.T | Nichi-Iko Pharmaceutical Co Ltd | 6.6 | 0.32 | 0.06 |
4577.T | Daito Pharmaceutical Co Ltd | 0.27 | 0.36 | 0.3 |
4581.T | Taisho Pharmaceutical Holdings Co Ltd | 0 | -0.18 | -0.18 |
Low | High | |
Unlevered beta | 0.24 | 0.32 |
Relevered beta | 0.43 | 0.57 |
Adjusted relevered beta | 0.62 | 0.71 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 4506.T:
cost_of_equity (6.30%) = risk_free_rate (1.65%) + equity_risk_premium (6.60%) * adjusted_beta (0.62) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.